• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MINIMED RPL MMT-7811W3 XMTR GST3C LOCKOUT 2.2A; SENSOR, GLUCOSE, INVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MINIMED RPL MMT-7811W3 XMTR GST3C LOCKOUT 2.2A; SENSOR, GLUCOSE, INVASIVE Back to Search Results
Model Number MMT-7811W3
Device Problems Display or Visual Feedback Problem (1184); Battery Problem (2885); Communication or Transmission Problem (2896); Wireless Communication Problem (3283)
Patient Problem Hypoglycemia (1912)
Event Date 02/24/2022
Event Type  malfunction  
Manufacturer Narrative
Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.
 
Event Description
Information received by medtronic indicated that the charger was blinking solid green.Customer stated that the transmitter was malfunctioned.No harm requiring medical intervention was reported.Troubleshooting was not performed, the customer will continue the use of device.
 
Manufacturer Narrative
No physical damage to connector pins, cow catcher or case was noted per visual inspection.No traces of moisture / contamination were noted at connector per visual inspection.Unit was able to charge up to two hours.After removing device from charger, the green led flashed properly.After the test plug was installed, the led flashed properly.Unit was able to communicate and sync properly during rf association.No rf communication anomalies noted.Unit passed functional tests including rf and accuracy test.Unable to confirm allegation of low bgs.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported that the transmitter was return for analysis.The customer had loss of communication between transmitter and insulin pump, and insulin alarm history showed lost sensor signal, sensor signal not found, cannot find sensor signal alarm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RPL MMT-7811W3 XMTR GST3C LOCKOUT 2.2A
Type of Device
SENSOR, GLUCOSE, INVASIVE
Manufacturer (Section D)
MEDTRONIC MINIMED
18000 devonshire st.
northridge CA 91325
Manufacturer (Section G)
MEDTRONIC MINIMED
18000 devonshire st.
northridge CA 91325
Manufacturer Contact
tricha miles
18000 devonshire st.
northridge, CA 91325
7635140379
MDR Report Key13645820
MDR Text Key287795820
Report Number2032227-2022-119627
Device Sequence Number1
Product Code MDS
UDI-Device Identifier000000763000400668
UDI-Public(01)000000763000400668
Combination Product (y/n)N
Reporter Country CodeSA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Distributor
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 12/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberMMT-7811W3
Device Catalogue NumberMMT-7811W3
Device Lot NumberA000846832
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/24/2022
Initial Date FDA Received03/02/2022
Supplement Dates Manufacturer Received08/10/2022
12/12/2022
Supplement Dates FDA Received09/08/2022
12/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/27/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-